InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Wednesday, 03/24/2021 9:14:23 PM

Wednesday, March 24, 2021 9:14:23 PM

Post# of 233271
Did CytoDyn management directly give us the critical numbers of 47% mortality in the placebo arm and 38% mortality in the treatment arm or were those numbers deduced from when Nader said the absolute reduction was 9% and the relative reduction was 24%?

38% mortality in the leronlimab arm of the critical patients is not good no matter if the placebo arm had 47% mortality. I realize these patients were critical but still. 62% survival just isn't a good result.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News